December 4-8, 2017 at Atlantic City, New Jersey
The 73rd Deming Conference on Applied Statistics
Sponsored by Metropolitan Section, ASQ and Biopharmaceutical Section, ASA
   
Biosketch
      

Back to Program



Qi Jiang

 
Dr. Qi Jiang is an executive director of Global Biostatistical Science at Amgen. In this role, she is biostatistical therapeutic area head for oncology and hematology and is the lead of the Center of Excellence for Safety and Benefit-Risk. In addition, Qi provides oversight to Amgen’s biostatistical efforts in the Asia-Pacific region. Before joining Amgen, Qi worked at the Harvard School of Public Health, Merck, and Novartis. Dr. Jiang is an editor of a book “Quantitative Evaluation of Safety in Drug Development” and also an editor of a book “Benefit-Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments”. In addition, Dr. Jiang is the author of more than 60 peer-reviewed publications on method development, study design, and data analysis and reporting. She is a fellow of the American Statistical Association, a co-lead of the American Statistical Association Biopharmaceutical Section Safety Working Group, a co-lead of the Quantitative Sciences in the Pharmaceutical Industry (QSPI) Benefit–Risk Working Group, and an associate editor for Statistics in Biopharmaceutical Research.

Back to Program